Reply to: 'composite endpoints for detecting meaningful changes in trials of headache treatments'.

Detecting meaningful changes in trials of headache treatments: which outcome measure is best? Cephalalgia (2012) 1.99

Composite endpoints for detecting meaningful changes in trials of headache treatments. Cephalalgia (2013) 1.09

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Pharmacoeconomics (2013) 2.21

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ (2013) 2.21

The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache (2013) 2.16

Migraine with aura and increased risk of ischaemic stroke. BMJ (2009) 2.12

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09

Detecting meaningful changes in trials of headache treatments: which outcome measure is best? Cephalalgia (2012) 1.99

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health (2013) 1.89

Restoring the integrity of the clinical trial evidence base. BMJ (2013) 1.74

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care (2013) 1.66

Missing clinical trial data. BMJ (2012) 1.61

Body mass index and episodic headaches: a population-based study. Arch Intern Med (2007) 1.54

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Clin Ther (2013) 1.53

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. J Med Econ (2013) 1.49

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med (2013) 1.44

The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache (2015) 1.30

Registration of observational studies. BMJ (2010) 1.28

The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache (2012) 1.02

Meditation for migraines: a pilot randomized controlled trial. Headache (2014) 0.97

Quality in the provision of headache care. 1: systematic review of the literature and commentary. J Headache Pain (2012) 0.97

Missing clinical trial data: setting the record straight. BMJ (2010) 0.97

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Eur J Health Econ (2013) 0.93

The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache (2015) 0.93

Quality in the provision of headache care. 2: defining quality and its indicators. J Headache Pain (2012) 0.92

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes (2007) 0.91

Tension-type headache. BMJ (2008) 0.89

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Cost Eff Resour Alloc (2013) 0.88

American headache through the decades: 1950 to 2008. Headache (2008) 0.84

Measuring pain intensity in headache trials: which scale to use? Cephalalgia (2012) 0.83

The evolution and geographic distribution of headache medicine fellowship programs and graduates: an observational study. Headache (2014) 0.81

The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin (2006) 0.81

Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache (2007) 0.80

Manual therapy versus usual GP care for chronic tension-type headache: we now have better evidence, but important questions remain. Cephalalgia (2010) 0.79

Factors associated with emergency department visits for migraine: an observational study. Headache (2014) 0.79

Taking the sting out of lumbar puncture. BMJ (2013) 0.79

Transient facial nerve palsy after occipital nerve block: a case report. Headache (2014) 0.78

Beta-blockers for migraine. Headache (2008) 0.78

Biomarkers in migraine: their promise, problems, and practical applications. Headache (2006) 0.76

Design considerations in migraine with aura trials: learning from experience. Cephalalgia (2010) 0.76

Responses to treatment of acute migraine headache article. Am Fam Physician (2011) 0.75

Menstrual migraine: timing is everything. Neurology (2004) 0.75

When can successful migraine prophylaxis be discontinued? Headache (2004) 0.75

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. Pharmacoeconomics (2015) 0.75

A theme issue in 2011 on unpublished evidence. BMJ (2011) 0.75

More on migraine and coronary artery disease. Headache (2003) 0.75

Chronic daily headache as a philosophical issue. Headache (2008) 0.75

Women and headache: a treatment approach based on life stages. Cleve Clin J Med (2002) 0.75

Mind/Body and behavioral treatments: the evidence and approach. Headache (2012) 0.75

Cluster headache treatment dilemmas: the experts respond. Curr Pain Headache Rep (2007) 0.75

Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations. Headache (2011) 0.75

Sponsorship, authorship, and accountability. N Engl J Med (2002) 0.75

Colonic explosions, chimpanzees' rear ends, and a source of green hair: this year's Ig Nobels. BMJ (2012) 0.75